Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
jueves, noviembre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Cameco Corp
CCJ
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$62.44
-2.07
-3.21%
al cierre: Nov 18, 4:00 PM EST
$63.63
-0.88
-1.36%
Premercado: 5:59 AM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Dividendo:
La fecha límite del dividendo es dentro de 11 días
Cameco Financials
Cameco (CCJ) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Cameco Affirms FY2026 Sales Guidance of $2.398B-$2.580B vs $2.440B Est
Cameco (NYSE:CCJ) affirms FY2026 sales outlook from $2.398 billion-$2.580 billion to $2.398 billion-$2.580 billion vs $2.440 billion estimate.
Benzinga Newsdesk
PRO
Cameco Q3 Adj EPS $0.00 and Sales $619.000M Miss $767.666M Estimate
Cameco (TSX:CCO) reported quarterly sales of $619.000 million which missed the analyst consensus estimate of $767.666 million by 19.37 percent. This is a 0.65 percent increase over sales of $615.000 million the same
Benzinga Newsdesk
ExxonMobil, AbbVie On Deck Friday As Energy, Drug Growth Face Test
ExxonMobil headlines Friday’s reports, with investors watching whether strong energy production can sustain a sharp earnings recovery. AbbVie, Chevron, AstraZeneca, BP, Sanofi, General Dynamics, Regeneron
Benzinga Insights
PRO
Cameco Raises FY2026 Sales Guidance from $2.245B-$2.417B to $2.398B-$2.580B vs $2.390B Est
Cameco (NYSE:CCJ) raises FY2026 sales outlook from $2.245 billion-$2.417 billion to $2.398 billion-$2.580 billion vs $2.390 billion estimate.
Benzinga Newsdesk
PRO
Cameco Lowers FY2026 Sales Guidance from $3.130B-$3.370B to $2.398B-$2.580B vs $3.440B Est
Cameco (TSX:CCO) lowers FY2026 sales outlook from $3.130 billion-$3.370 billion to $2.398 billion-$2.580 billion vs $3.440 billion estimate.
Benzinga Newsdesk
PRO
Cameco Q2 Adj. EPS $0.13 Misses $0.36 Estimate, Sales $588.000M Beat $534.360M Estimate
Cameco (NYSE:CCJ) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.36 by 63.89 percent. This is a 74.51 percent decrease over earnings of $0.51 per share from the same
Benzinga Newsdesk